NYSE:AEON | Cash Flow Statement | AEON Biopharma, Inc.

Complete source-backed cash-flow history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.16M
2026-03-31-$11.79M$19,000.00-$2.64M$5.87M
2025-12-31-$37.14M$20,000.00-$4.71M$0.00$0.00$1.79M
2025-09-30-$4.54M
2025-06-30-$6.64M
2025-03-31$9.1M$19,000.00-$7.91M$4,000.00-$4,000.00$18.35M
2024-12-31$2.08M$23,000.00-$621,000.00$97,000.00
2024-09-30-$6.17M
2024-06-30$164.11M
2024-03-31-$118.02M$25,000.00-$8.6M$5M
2023-09-30-$297.71M$21,000.00-$15.06M
2023-06-30-$15.38M
2023-03-31-$17.64M$25,000.00-$11.06M$260.01M$6M
2022-12-31-$34.56M$32,000.00-$8.45M$9,000.00-$9,000.00-$3.99M
2022-09-30-$10.44M
2022-06-30$1.87M
2022-03-31$2.77M-$411,669.00$80,500.00
2021-12-31$247,874.00-$162,633.00$0.00-$3,495.00
2021-09-30$5.66M
2021-06-30-$4.03M
2021-03-31$6.32M-$554,518.00-$276M$278M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$39.22M$78,000.00-$17.31M$4,000.00-$4,000.00$20.31M
2024-12-31$42.01M$97,000.00-$20.29M$15.15M
2022-12-31-$52.56M$68,000.00-$35.58M$306,000.00-$306,000.00$40.51M
2021-12-31$8.2M-$1.49M-$276M$277.99M